I believe 14 cents is as it bounced repeatedly off it.
A narrow trading range would be most favourable for negotiations, so it keeps bouncing between 14 and 15 cents, bascially not exceeding MC of 500 mil, which seems the target.
In my humble opinion, a target of 1.5 bil MC is the goal to close the value gap between the US and OZ.
Some of it would be equity, some ownership related, some other funding options are also
available as those investors/ partners are a very different calibre to what we had to work with here.
After funding arrangements the price should move to 30 to 40 cents, 50 to 60 cents by mid next year with IND for first drug.
Good thing here is that news are expected mid Oct or thereabouts, we should exit the negotiation period before then.
My personal guess is to see events unfold for development and investor partnerships within next 3 weeks.
The Oppenheimer Fall summit appears to be the culmination of ongoing talks.
Those who lock price between 14 and 15 cents for such a long period would clearly act prior to news which would push price up inevitably, which can not be in their interest.
all IMO
PYC Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)